Explore more publications!

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on September 26, 2025

Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI
Membrane Bioreactor Market to Grow at 16.1% CAGR by 2030
New Fisher House Dedicated in Little Rock
Tekton Research Expands Clinical Network with Three New Sites, Five New Investigators, and CNS Thought Leader
24/7 Market News: Kraig Labs Offers Safer, Natural Alternative to Health Risks from Nylon and Polyester Clothing
Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025
Biofrontera Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
New Clue Survey Reveals Misinformation About Reproductive Health is a Top Concern for American Women
Un gala du siècle pour célébrer 100 ans d’espoir, de guérison et d’innovation aux Hôpitaux Shriners pour enfants Canada
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference
Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol
Harrow to Acquire Melt Pharmaceuticals
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
ADvantage Therapeutics Awarded $2.5 milion NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic
RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions